Packaged Foods
Compare Stocks
2 / 10Stock Comparison
HCWC vs OPRX
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Information Services
HCWC vs OPRX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Packaged Foods | Medical - Healthcare Information Services |
| Market Cap | $4M | $124M |
| Revenue (TTM) | $78M | $109M |
| Net Income (TTM) | $-4M | $5M |
| Gross Margin | 39.6% | 67.3% |
| Operating Margin | -1.5% | 10.7% |
| Forward P/E | — | 7.0x |
| Total Debt | $26M | $5M |
| Cash & Equiv. | $2M | $23M |
HCWC vs OPRX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 24 | May 26 | Return |
|---|---|---|---|
| Healthy Choice Well… (HCWC) | 100 | 11.4 | -88.6% |
| OptimizeRx Corporat… (OPRX) | 100 | 85.9 | -14.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HCWC vs OPRX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HCWC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 1.66
- Rev growth 24.6%, EPS growth 55.6%, 3Y rev CAGR 83.5%
- Lower volatility, beta 1.66, current ratio 0.81x
OPRX is the clearest fit if your priority is long-term compounding.
- 110.5% 10Y total return vs HCWC's -94.6%
- 4.7% margin vs HCWC's -5.4%
- 3.0% ROA vs HCWC's -11.7%, ROIC 7.1% vs -5.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 24.6% revenue growth vs OPRX's 18.8% | |
| Quality / Margins | 4.7% margin vs HCWC's -5.4% | |
| Stability / Safety | Beta 1.66 vs OPRX's 2.28 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -24.8% vs OPRX's -30.1% | |
| Efficiency (ROA) | 3.0% ROA vs HCWC's -11.7%, ROIC 7.1% vs -5.6% |
HCWC vs OPRX — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
OPRX leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
OPRX and HCWC operate at a comparable scale, with $109M and $78M in trailing revenue. OPRX is the more profitable business, keeping 4.7% of every revenue dollar as net income compared to HCWC's -5.4%. On growth, HCWC holds the edge at +29.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $78M | $109M |
| EBITDAEarnings before interest/tax | $2M | $16M |
| Net IncomeAfter-tax profit | -$4M | $5M |
| Free Cash FlowCash after capex | $2M | $12M |
| Gross MarginGross profit ÷ Revenue | +39.6% | +67.3% |
| Operating MarginEBIT ÷ Revenue | -1.5% | +10.7% |
| Net MarginNet income ÷ Revenue | -5.4% | +4.7% |
| FCF MarginFCF ÷ Revenue | +2.2% | +10.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +29.5% | -0.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +56.0% | — |
Valuation Metrics
HCWC leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $4M | $124M |
| Enterprise ValueMkt cap + debt − cash | $27M | $105M |
| Trailing P/EPrice ÷ TTM EPS | -0.59x | 24.56x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 7.04x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 6.55x |
| Price / SalesMarket cap ÷ Revenue | 0.05x | 1.13x |
| Price / BookPrice ÷ Book value/share | 1.13x | 0.98x |
| Price / FCFMarket cap ÷ FCF | — | 6.62x |
Profitability & Efficiency
OPRX leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
OPRX delivers a 4.2% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $-74 for HCWC. OPRX carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to HCWC's 10.72x. On the Piotroski fundamental quality scale (0–9), OPRX scores 8/9 vs HCWC's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -73.9% | +4.2% |
| ROA (TTM)Return on assets | -11.7% | +3.0% |
| ROICReturn on invested capital | -5.6% | +7.1% |
| ROCEReturn on capital employed | -8.5% | +7.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 8 |
| Debt / EquityFinancial leverage | 10.72x | 0.04x |
| Net DebtTotal debt minus cash | $23M | -$19M |
| Cash & Equiv.Liquid assets | $2M | $23M |
| Total DebtShort + long-term debt | $26M | $5M |
| Interest CoverageEBIT ÷ Interest expense | -1.15x | 1.26x |
Total Returns (Dividends Reinvested)
OPRX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in OPRX five years ago would be worth $1,266 today (with dividends reinvested), compared to $544 for HCWC. Over the past 12 months, HCWC leads with a -24.8% total return vs OPRX's -30.1%. The 3-year compound annual growth rate (CAGR) favors OPRX at -23.0% vs HCWC's -62.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +1.5% | -46.6% |
| 1-Year ReturnPast 12 months | -24.8% | -30.1% |
| 3-Year ReturnCumulative with dividends | -94.6% | -54.4% |
| 5-Year ReturnCumulative with dividends | -94.6% | -87.3% |
| 10-Year ReturnCumulative with dividends | -94.6% | +110.5% |
| CAGR (3Y)Annualised 3-year return | -62.1% | -23.0% |
Risk & Volatility
Evenly matched — HCWC and OPRX each lead in 1 of 2 comparable metrics.
Risk & Volatility
HCWC is the less volatile stock with a 1.66 beta — it tends to amplify market swings less than OPRX's 2.28 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.66x | 2.28x |
| 52-Week HighHighest price in past year | $0.98 | $22.25 |
| 52-Week LowLowest price in past year | $0.22 | $5.54 |
| % of 52W HighCurrent price vs 52-week peak | +29.1% | +29.8% |
| RSI (14)Momentum oscillator 0–100 | 56.8 | 46.9 |
| Avg Volume (50D)Average daily shares traded | 500K | 476K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $17.00 |
| # AnalystsCovering analysts | — | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
OPRX leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HCWC leads in 1 (Valuation Metrics). 1 tied.
HCWC vs OPRX: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is HCWC or OPRX a better buy right now?
For growth investors, Healthy Choice Wellness Corp.
(HCWC) is the stronger pick with 24. 6% revenue growth year-over-year, versus 18. 8% for OptimizeRx Corporation (OPRX). OptimizeRx Corporation (OPRX) offers the better valuation at 24. 6x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate OptimizeRx Corporation (OPRX) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — HCWC or OPRX?
Over the past 5 years, OptimizeRx Corporation (OPRX) delivered a total return of -87.
3%, compared to -94. 6% for Healthy Choice Wellness Corp. (HCWC). Over 10 years, the gap is even starker: OPRX returned +110. 5% versus HCWC's -94. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — HCWC or OPRX?
By beta (market sensitivity over 5 years), Healthy Choice Wellness Corp.
(HCWC) is the lower-risk stock at 1. 66β versus OptimizeRx Corporation's 2. 28β — meaning OPRX is approximately 37% more volatile than HCWC relative to the S&P 500. On balance sheet safety, OptimizeRx Corporation (OPRX) carries a lower debt/equity ratio of 4% versus 11% for Healthy Choice Wellness Corp. — giving it more financial flexibility in a downturn.
04Which is growing faster — HCWC or OPRX?
By revenue growth (latest reported year), Healthy Choice Wellness Corp.
(HCWC) is pulling ahead at 24. 6% versus 18. 8% for OptimizeRx Corporation (OPRX). On earnings-per-share growth, the picture is similar: OptimizeRx Corporation grew EPS 124. 5% year-over-year, compared to 55. 6% for Healthy Choice Wellness Corp.. Over a 3-year CAGR, HCWC leads at 83. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — HCWC or OPRX?
OptimizeRx Corporation (OPRX) is the more profitable company, earning 4.
7% net margin versus -6. 5% for Healthy Choice Wellness Corp. — meaning it keeps 4. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OPRX leads at 10. 7% versus -2. 6% for HCWC. At the gross margin level — before operating expenses — OPRX leads at 67. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — HCWC or OPRX?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is HCWC or OPRX better for a retirement portfolio?
For long-horizon retirement investors, Healthy Choice Wellness Corp.
(HCWC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. OptimizeRx Corporation (OPRX) carries a higher beta of 2. 28 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HCWC: -94. 6%, OPRX: +110. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between HCWC and OPRX?
These companies operate in different sectors (HCWC (Consumer Defensive) and OPRX (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.